NSEOutcome of Board Meeting2d ago · 4 Nov 2026, 01:58 pm
Outcome of Board Meeting
Jyothy Labs Limited · JYOTHYLAB
✦ AI SummaryResults
Jyothy Labs Limited has informed the Exchange regarding Outcome of Board Meeting held on November 04, 2026. The Board has approved the Unaudited Financial Results and Statements for the quarter and half-year ended September 30, 2026, and also approved a buyback of up to 68,37,210 equity shares at a price of ₹215 per share.
Analysis Scores
Earnings Impact6/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Jyothy Labs Limited has informed the Exchange regarding Outcome of Board Meeting held on November 04, 2026.
Attachments (1)
📄pdf
Download →
JYOTHYLAB_04112026135156_SEIntimationOutcomeBM.pdf
View document text
Jyothy labs
November 04, 2026
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers, Exchange Plaza, Sandra - Kurla Complex,
Dalal Street, Mumbai - 400 001 Sandra (E), Mumbai -400 051
BSE Scrip Code: 532926 NSE Symbol: JYOTHYLAB
Dear Sir/ Madam,
Sub: Outcome of the Board Meeting held on November 4, 2026 pursuant to Regulation
30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure
Requirements) Regulations, 2015 ("SEBI Listing Regulations").
Further to our letters dated October 13, 2026 and October 30, 2026 and in terms of Regulation
30 of SEBI Listing Regulations, we wish to inform you that the Board of the Company, at its
meeting held today i.e., November 4, 2026, which commenced at 11 :00 a.m. and concluded
at I • .l.tO p.m., has inter-alia, considered and approved:
1. Unaudited Financial Results and Statements for the quarter and half-year ended
September 30, 2026:
The Unaudited Financial Results for the quarter and half-year ended September 30,
2026, with the Limited Review Report by the Statutory Auditors of the Company.
Accordingly, in terms of Regulation 33 of the SEBI Listing Regulations, enclosed
herewith is a copy of the Un-audited Financial Results for the quarter and half-year
ended September 30, 2026, accompanied with the Limited Review Report by the
Statutory Auditors of the Company. Refer Annexure A.
2. Buyback of Equity Shares of Jyothy Labs Limited ("the Company") through tender
offer route:
The proposal to buyback up to 68,37,210 (Sixty Eight Lakhs Thirty- Seven Thousand
Two Hundred and Ten) fully paid-up equity shares of the Company, having face value
of ~1/- (Indian Rupees One only) each ("Equity Shares"), representing 1.86 % of the
total number of equity shares in the total paid-up equity share capital of the Company
as at March 31, 2026, at a price of~ 215 (Indian Rupees Two Hundred And Fifteen
Only) per Equity Share ("Buyback Price"), payable in cash, for an aggregate amount
of up to 147,00,00, 150 (Indian Rupees One Hundred Forty-Seven Crore One Hundred
Fifty only) ("Buyback Size") (excluding any expenses incurred or to be incurred for the
buyback, such as, brokerage, turnover charges, filing fees to SEBI, stock exchange
Jyothy Labs Limited
CIN: L24240MH1992PLC128651
'Ujala House', Ramkrishna Mandir Road,
Kondivita. Andheri (East), Mumbai 400 059.
Tel: +91 022-6689 2800
info@jyothy.com I www.jyothylabs.com
• Jyothy labs
charges, advisory fees, legal fees, intermediaries' fees, statutory auditor's fees,
certification charges, public announcement publication expenses, printing and dispatch
expenses, applicable taxes such as securities transaction tax, goods and services tax,
stamp duty etc. and other incidental and related expenses ("Transaction Costs"). The
Buyback Size represents 9.70% of the aggregate of the fully paid-up equity share
capital and free reserves of the Company as per the audited financial statements for
the financial year ended March 31, 2026, and is within the statutory limit of 10% of the
aggregate of the fully paid-up equity share capital and free reserves under the Board
approval route, ("Buyback").
The Buyback is proposed to be made from all eligible equity shareholders/beneficial
owners of the Equity Shares of the Company as on the Record Date (as mentioned
below), in accordance with the provisions contained in the Securities and Exchange
Board of India (Buy-Back of Securities) Regulations, 2018, as amended ("Buyback
Regulations") and the Companies Act, 2013, as amended and rules made thereunder;
3. The Board has noted that the promoter and promoter group of the Company have vide
a letter dated November 4, 2026 expressed their intention not to participate in the
Buyback.
4. The formation of a buyback committee ("Buyback Committee") and delegated its
powers to the Buyback Committee to do all such acts, deeds, matters and things as it
may, in its absolute discretion, deem necessary, expedient, usual or proper in
connection with the Buyback;
5. Wednesday, November 11, 2026 as the record date ("Record Date") for the purpose
of determining the entitlement and the names of equity shareholders/ beneficial owners
of Equity Shares who shall be eligible to participate in the Buyback, pursuant to
Regulation 42 of the SEBI Listing Regulations, as amended, and Regulation 9(i) of the
SEBI Buyback Regulations, as amended.
In terms of Regulation 5(via) of the Buyback Regulations, the Board/Buyback Committee may,
till 1 (one) working day prior to the Record Date, increase the Buyback Price and decrease
the number of Equity Shares proposed to be bought back, such that there is no change in the
Buyback Size.
The pre-Buyback shareholding pattern as on October 30, 2026, is enclosed as Annexure 8.
Please note that the details regarding the post-Buyback shareholding pattern have not been
provided since the actual number of Equity Shares that are bought back and category of
shareholders from whom the Equity Shares will be bought back can be determined after the
Record Date.
The public announcement and the letter of offer setting out the process, timelines, and other
requisite details will be released in due course in accordance with the Buyback Regulations.
The relevant details as per S~E-B-~I · Master Circular No. HO/49/14/14(7)2025-CFD
POD/2/1 /3762/2026 dated January ~Q,"'"2026, are given as Annexure C.
Jyothy Labs Limited
/""'-"". CIN: L24240MH1992PLC128651
( 'Ujala House', Ramkrishna Mandir Road,
Kondivita, Andheri (East), Mumbai 400 059.
Tel: +91 022-6689 2800
0 211'1'\' info@jyothy.com I www.jyothylabs.com
• Jyothy labs
Kindly take the above on your record and disseminate the same for the information of
investors.
Thanking you,
Yours faithfully,
For Jyothy Labs Limited
TC))
YNl,i. ~- -
Shreyas Trivedi ·
Head - Legal & Company Secretary
Jyothy Labs Limited
CIN: L24240MH1992PLC128651
'Ujala House', Ramkrishna Mandir Road.
Kondivita. Andheri (East). Mumbai 400 059.
Tel: +91 022-6689 2800
info@jyothy.com I www.jyothylabs.com
A N N -r~v e G- A
BS R & Co. LLP 14th Floor, Central B Wing and North C Wing
Nesco IT Park 4, Nesco Center
Western Express Highway
Chartered Accountants
Goregaon (East), Mumbai - 400 063, India
Telephone: +91 (22) 6257 1000
Fax: +91 (22) 6257 1010
Limited Review Report on unaudited financial results of J_yothy Labs Limited for the
quarter ended 30 September 2026 and year to date results for the period from 1 April
2026 to 30 September 2026 pursuant to Regulation 33 of Securities and Exchange
Board of India {Listing Obligations and Disclosure Requirements) Regulations, 2015,
as amended
To the Board of Directors of Jyothy Labs Limited
1. We have reviewed the accompanying Statement of unaudited financial results of Jyothy Labs Limited
(hereinafter referred to as "the Company") for the quarter ended 30 September 2026 and year to date
results for the period from 1 April 2026 to 30 September 2026 ("the Statement").
2. This Statement, which is the responsibility of the Company's management and approved by its Board
of Directors, has been prepared in accordance with the recognition and measurement principles laid
down in Indian Accounting Standard 34 "Interim Financial Reporting" ("Ind AS 34"), prescribed under
Section 133 of the Companies Act, 2013, and other accounting principles generally accepted in India
and in compliance with Regulation 33 of the Securities and Exchange Board of India (Listing
Obligations and Disclosure Requirements) Regulations, 2015, as amended ("Listing Regulations").
Our responsibility is to issue a report on the Statement based on our review.
3. We conducted our review of the Statement in accordance with the Standard on Review Engagements
(SRE) 2410 "Review of Interim Financial Information Performed by the Independent Auditor of the
Entity", issued by the Institute of Chartered Accountants of India. A review of interim financial
information consists of making inquiries, primarily of persons responsible for financial and accoun
[Showing first 8,000 characters — download PDF for full document]